|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.380 USD | +9.66% |
|
+52.48% | +235.45% |
| Dec. 09 | Immix Biopharma announces closing of upsized $100 million underwritten offering of common stock and pre-funded warrants | RE |
| Dec. 08 | Immix Biopharma Prices $100 Million Offering | MT |
Evolution of the Average Target: Immix Biopharma, Inc.
Evolution of the Target Price: Immix Biopharma, Inc.
Changes in Analyst Recommendations: Immix Biopharma, Inc.
8db4ccd90d.SVrAirWCgbB_XOuL6nHHStRWxGCpke99S9sArgZPnk4.DCj03ofQ99Y9OZPAgjidOKYhmwfM5ZweA4hpn3IEzBYWLpPCz8fY6UYb2w~b55e67752b655bf8b647ee3d18f5f6e7
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | +7.72% | ||||
| +5.35% | |||||
| +15.19% | |||||
| +34.99% | |||||
| +44.58% | |||||
| +1.82% | |||||
| +18.05% | |||||
| +78.32% | |||||
| +45.57% | |||||
| -0.03% | |||||
| Average | +25.16% | |||||
| Weighted average by Cap. | +22.81% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
7.380USD
Average target price
7.950USD
Spread / Average Target
+7.72%
High Price Target
12.00USD
Spread / Highest target
+62.60%
Low Price Target
3.900USD
Spread / Lowest Target
-47.15%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| Roth MKM |
SellBuy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
7.380USD
Average target price
7.950USD
Spread / Average Target
+7.72%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- IMMX Stock
- Consensus Immix Biopharma, Inc.
Select your edition
All financial news and data tailored to specific country editions
